Cancer Horizons

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berger, who recently spo

S7 Ep1: The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another cancer vaccine clinica

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them

S6 Ep20: FDA Approvals from February 2024

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. The week’s first app

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

Last week, we saw some FDA approvals for a new drug regimens, as well as some expert opinion about cancer vaccines. Additionally research touched upon the potential benefit of concurrent ctDNA and tumor testing, and phys

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews. Also last week, we covered research showing that a low

S6 Ep17: FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Last week, we saw some research regarding how a popular tool used to plan breast cancer treatment may be misguiding therapy for Black women, as well as an update on when we can expect to see a new cancer vaccine be readi

S6 Ep16: Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

It’s been a busy few weeks here at CURE® and in the oncology space as a whole, as the last two weekends had back-to-back meetings: the American Society of Clinical Oncology’s Gastrointestinal Cancers Symposium , and then

S6 Ep15: Prostate Cancer Headlines, CAR-T Warnings and Laughter Therapy

Last week, we saw some big headlines in the oncology space, from Dexter Scott King’s death from prostate cancer and MLB Hall-of-Famer Ryne Sandberg announcing that he was diagnosed with the disease. The FDA also requeste

S6 Ep14: How a Cancer Journey Connects Oncologist to His Patients

Often, receiving a cancer diagnosis can require a crash course in oncology that few patients ever expected to take. For colorectal cancer specialist Dr. Dustin Deming, the ACI/Schwenn Family associate professor in the di

S6 Ep13: A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

It wasn’t even two weeks into the new year when the Food and Drug Administration made their first FDA approval. In this case, it was a Keytruda regimen for certain patients with gynecologic cancers. We at CURE® spoke wit

S6 Ep12: FDA Gives Cancer Drug Updates, Prostate Cancer Trial Enrolls Patients

This week in oncology news, we saw a few decisions from the Food and Drug Administration, ranging from the agency agreeing to review a drug and potentially grant it a full approval to their citing manufacturing concerns

S6 Ep11: ‘Stand Up For Yourself’: Facing Thyroid Cancer With Urgency, Positivity

Kate Rice is proof of the power of persistence and positivity while navigating a cancer journey. Rice, an award-winning journalist, received a diagnosis of stage 4 anaplastic thyroid cancer in October 2021 — and quickly

S6 Ep10: FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis

The year 2024 is now underway. After a busy 2023, we’re now looking back at some of the oncology headlines from the new year. Notably, we have a clinical trial hold for a lung cancer drug, a trial that showed that a CAR-

S6 Ep9: Top Cancer Headlines from 2023: From Jimmy Buffett’s Death to the Chemo Shortage

The year 2023 has come and gone, and we figured that now is the perfect time to look back on some of the top cancer-related stories from the year. Vitamin D May Impact Colorectal Cancer Outcomes In June, we spoke to an e

S6 Ep8: FDA Approves 3 Treatments, Cancer Vaccine Shows Promise

The FDA is certainly staying busy as 2023 comes to a close, approving three treatments for patients with cancer last week alone. Additionally, exciting study findings were released regarding a cancer vaccine for the trea

S6 Ep7: Conference Highlights from the 2023 ASH Annual Meeting

This past weekend, the CURE® staff was busy covering the American Society of Hematology (ASH) Annual Meeting. ASH is the largest blood cancer conference in the country, and thousands of abstracts were presented. Now, we’

S6 Ep6: Conference Highlights from SABCS

The last week was a busy one for us here at CURE® and across the oncology space in general. There were two major meetings we covered: the San Antonio Breast Cancer Symposium and the American Society of Hematology Annual